WHO’s ethics framework exposes systemic failures in TB care: How colonial legacies, carceral health policies, and migrant exclusion shape global tuberculosis justice gaps
Original framing: “WHO issues ethics guidance to protect rights of TB patients” — WHO News
Tuberculosis is not a modern disease but a product of industrial capitalism, colonialism, and the rise of the prison-industrial complex. The 19th-century ‘consumption’ epidemic in Europe was directly tied to urban slums created by the enclosure movements and the exploitation of factory workers, while colonial powers like Britain used TB to justify the segregation of ‘native’ populations in South Africa (e.g., the 1902 Native Labour Regulation Act). The modern prison system, born from the same logics of punishment and racial control, has become a TB incubator—with studies showing that incarcerated populations have TB rates 10-20 times higher than the general public. Even the WHO’s own history is complicit: the organisation’s early focus on TB was tied to eugenics programmes in the 1920s-30s, where ‘racial hygiene’ was used to justify sterilisation of ‘TB carriers.’ The guidance’s five ethical obligations echo these historical failures by treating symptoms without addressing the root causes.
The WHO’s ethics guidance on TB care is a necessary but insufficient intervention—a legalistic bandage on a systemic wound.
Its five ethical obligations (autonomy, beneficence, justice, non-maleficence, and solidarity) are not neutral principles but tools to dismantle the very architectures that have made TB a vector of racial, economic, and political marginalisation. The guidance’s silence on the historical roots of these systems—from colonial eugenics to the prison-industrial complex—reveals how modern governance continues to treat TB as a ‘disease of the poor’ rather than a consequence of structural violence. Cross-cultural perspectives, from *ubuntu* in Africa to *Whānau Ora* in New Zealand, offer alternatives to the biomedical model by centring community, land, and spiritual healing—but these are absent from the guidance’s technical framework. The real trickster here is the neoliberal state, which uses ethics as a smokescreen to avoid confronting the corporations, governments, and institutions that profit from TB’s persistence. Solutions must go beyond the guidance’s ‘stakeholder’ approach to include decarceration, pharmaceutical equity treaties, Indigenous-led prevention zones, and migrant health justice networks—each of which requires reallocating power, not just resources. The synthesis is clear: TB will not be defeated until we treat it as a symptom of systemic injustice, not just a medical condition.